Related Experiment Video

Updated: May 25, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Targeted therapy in bone and soft tissue sarcoma in children and adolescents

Patrick A Thompson1, Murali Chintagumpala

  • 1Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX 77030-2399, USA. pathomps@txch.org

Current Oncology Reports
|February 4, 2012
PubMed

Insights

New targeted therapies show promise for improving cure rates in pediatric sarcomas, moving beyond traditional chemotherapy. Research focuses on specific tumor abnormalities for better outcomes in children with soft-tissue and bone cancers.

Area of Science:

  • Pediatric oncology
  • Cancer biology
  • Translational research

Background:

  • Pediatric soft-tissue and bone sarcomas are rare, aggressive cancers affecting ~1,500 US children annually.
  • Current multimodal therapy (surgery, radiation, chemotherapy) yields 60%-70% 5-year survival, with limited improvement for metastatic/recurrent cases.
  • Advances in cytotoxic chemotherapy have plateaued, necessitating novel treatment strategies.

Purpose of the Study:

  • To review the biology of major pediatric sarcomas.
  • To identify potential molecular targets for novel therapies.
  • To highlight current clinical trials investigating targeted treatments.

Main Methods:

  • Literature review of pediatric sarcoma biology.
  • Analysis of research on tumor-specific abnormalities.
  • Summary of ongoing clinical trials for targeted therapies.

Main Results:

  • Understanding sarcoma biology reveals specific molecular targets.
  • Targeted therapies (small molecules, antibodies, immunotherapies) offer new treatment avenues.
  • Clinical trials are actively exploring these novel approaches in pediatric patients.

Conclusions:

  • Future improvements in pediatric sarcoma cure rates depend on targeted therapies.
  • Targeted treatments address specific tumor abnormalities, offering greater efficacy than traditional chemotherapy.
  • Ongoing research and clinical trials are crucial for advancing pediatric sarcoma treatment.

More Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...